Log In
BCIQ
Print this Print this
 

Pollinex-R Ragweed vaccine

  Manage Alerts
Collapse Summary General Information
Company Allergy Therapeutics plc
DescriptionSubcutaneous ragweed allergy vaccine formulated with allergoids and tyrosine
Molecular Target
Mechanism of ActionImmunotherapy
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationAllergy
Indication DetailsTreat ragweed allergy
Regulatory Designation
PartnerEndo International plc;
Takeda Pharmaceutical Co. Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/14/2013

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today